NCT06569381View on ClinicalTrials.gov

Comparative Pharmacokinetic Study of Pirfenidone Modified-Release Tablets in Healthy Subjects Under Fasting and Fed Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

September 18, 2024

Primary Completion Date

October 1, 2024

Study Completion Date

December 8, 2024

Conditions
Idiopathic Pulmonary Fibrosis
Interventions
DRUG

Pirfenidone Modified-Release Tablets

take the tablet under fasting condition, 1 tablet at a time, once a day.

DRUG

Pirfenidone Modified-Release Tablets

take the tablet under fed condition, 1 tablet at a time, once a day.

Trial Locations (1)

266000

The Affiliated Hospital of Qingdao University, Qingdao

Sponsors
All Listed Sponsors
collaborator

Shanghai ShouYan Clinical Development Co.,Ltd.

UNKNOWN

lead

Overseas Pharmaceuticals, Ltd.

INDUSTRY

NCT06569381 - Comparative Pharmacokinetic Study of Pirfenidone Modified-Release Tablets in Healthy Subjects Under Fasting and Fed Conditions | Biotech Hunter | Biotech Hunter